US Stock MarketDetailed Quotes
NUTX Nutex Health
- 5.9800
- +0.0300+0.50%
Trading Jul 16 12:45 ET
29.73MMarket Cap-636P/E (TTM)
6.1869High5.8500Low51.49KVolume5.9800Open5.9500Pre Close308.01KTurnover1.84%Turnover RatioLossP/E (Static)4.97MShares63.000052wk High0.47P/B16.70MFloat Cap4.160052wk Low--Dividend TTM2.79MShs Float7920.0000Historical High--Div YieldTTM5.66%Amplitude4.1600Historical Low5.9820Avg Price1Lot Size
Nutex Health Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.75%67.45M | 12.93%247.65M | 29.68%69.67M | 120.89%62.72M | 1.51%58.92M | -28.81%56.33M | -33.85%219.29M | -15.26%53.72M | -75.93%28.4M | -7.59%58.05M |
| Operating revenue | 19.75%67.45M | 12.93%247.65M | 29.68%69.67M | 120.89%62.72M | 1.51%58.92M | -28.81%56.33M | -33.85%219.29M | -15.26%53.72M | -75.93%28.4M | -7.59%58.05M |
| Cost of revenue | 11.30%57.3M | 4.41%212.87M | -1.03%56.46M | 6.81%55.66M | -4.15%49.28M | 18.86%51.48M | 33.91%203.87M | 29.89%57.04M | 24.18%52.11M | 52.65%51.41M |
| Gross profit | 109.52%10.16M | 125.49%34.77M | 498.14%13.21M | 129.80%7.07M | 45.33%9.65M | -86.46%4.85M | -91.40%15.42M | -117.03%-3.32M | -131.20%-23.71M | -77.22%6.64M |
| Operating expense | -6.30%8.71M | 81.41%36.28M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 41.30%9.29M | 266.15%20M | 523.42%2.46M | 342.06%6.83M | 169.45%4.13M |
| Selling and administrative expenses | -4.05%8.71M | 80.33%36.07M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 38.00%9.08M | 266.15%20M | 523.42%2.46M | 342.06%6.83M | 169.45%4.13M |
| -General and administrative expense | -4.05%8.71M | 80.33%36.07M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 38.00%9.08M | 266.15%20M | 523.42%2.46M | 342.06%6.83M | 169.45%4.13M |
| Other operating expenses | ---- | --217.27K | --0 | ---- | ---- | --217.27K | ---- | ---- | ---- | ---- |
| Operating profit | 132.61%1.45M | 67.05%-1.51M | 170.54%4.08M | 97.45%-777.76K | -114.46%-362.54K | -115.20%-4.45M | -102.63%-4.58M | -130.27%-5.78M | -141.02%-30.55M | -90.92%2.51M |
| Net non-operating interest income expense | -41.54%-4.44M | -30.64%-16.32M | -48.02%-4.24M | -20.44%-4.1M | -10.83%-4.84M | -69.19%-3.14M | -101.59%-12.49M | -47.17%-2.86M | -170.01%-3.4M | -190.35%-4.37M |
| Non-operating interest expense | 41.54%4.44M | 30.64%16.32M | 48.02%4.24M | 20.44%4.1M | 10.83%4.84M | 69.19%3.14M | 101.59%12.49M | 47.17%2.86M | 170.01%3.4M | 190.35%4.37M |
| Other net income (expense) | 1,248.47%2.84M | 92.38%-30.66M | -14,281.46%-30.55M | 100.00%9.74K | 104.98%123.53K | 89.61%-247.46K | -21,646.46%-402.58M | 94.41%-212.43K | -22,876.02%-397.5M | -161.14%-2.48M |
| Gain on sale of security | --2.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | ---- | 92.47%-30.26M | ---30.22M | 99.99%-43.46K | --0 | ---- | -11,212.69%-402.02M | --0 | ---398.14M | ---3.89M |
| -Less：Restructuring and merger&acquisition | ---- | -98.88%43.46K | --0 | --43.46K | --0 | ---- | 9.34%3.89M | --0 | --0 | --3.89M |
| -Less:Impairment of capital assets | ---- | -92.41%30.22M | --30.22M | --0 | ---- | ---- | --398.14M | --0 | --398.14M | ---- |
| Other non- operating income (expenses) | 197.47%241.19K | 28.63%-399.18K | -54.62%-328.46K | -91.56%53.21K | -91.20%123.53K | 89.61%-247.46K | -110.32%-559.3K | 13.11%-212.43K | -63.88%630.45K | -65.44%1.4M |
| Income before tax | 98.05%-152.82K | 88.44%-48.49M | -246.87%-30.71M | 98.87%-4.87M | -16.97%-5.08M | -131.33%-7.83M | -347.59%-419.65M | -166.33%-8.85M | -675.67%-431.45M | -114.41%-4.34M |
| Income tax | 142.79%389.67K | -138.71%-5.07M | -266.11%-3M | 95.99%-342.26K | -104.15%-815.61K | -616.47%-910.66K | 1,255.54%13.09M | 1,529.91%1.81M | -1,983.48%-8.54M | 3,981.67%19.65M |
| Net income | 92.16%-542.49K | 89.97%-43.42M | -159.99%-27.71M | 98.93%-4.52M | 82.22%-4.27M | -127.88%-6.92M | -356.78%-432.74M | -179.10%-10.66M | -667.71%-422.91M | -180.86%-24M |
| Net income continuous Operations | 92.16%-542.49K | 89.97%-43.42M | -159.99%-27.71M | 98.93%-4.52M | 82.22%-4.27M | -127.88%-6.92M | -356.78%-432.74M | -179.10%-10.66M | -667.71%-422.91M | -180.86%-24M |
| Minority interest income | 89.95%-178.41K | 129.69%2.36M | -4.57%3.91M | 109.50%1.02M | 83.29%-787.4K | -152.45%-1.77M | -122.15%-7.96M | 911.37%4.09M | -151.80%-10.72M | -279.99%-4.71M |
| Net income attributable to the parent company | 92.93%-364.08K | 89.22%-45.79M | -114.33%-31.62M | 98.66%-5.54M | 81.96%-3.48M | -124.00%-5.15M | -420.36%-424.78M | -205.53%-14.75M | -866.24%-412.19M | -171.27%-19.28M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 92.93%-364.08K | 89.22%-45.79M | -114.33%-31.62M | 98.66%-5.54M | 81.96%-3.48M | -124.00%-5.15M | -420.36%-424.78M | -205.53%-14.75M | -866.24%-412.19M | -171.27%-19.28M |
| Basic earnings per share | 91.67%-1.5 | 89.55%-10.5 | -150.00%-7.5 | 98.39%-1.5 | 66.67%-1.5 | -460.25%-18 | -425.28%-100.5 | -192.10%-3 | -841.95%-93 | -171.37%-4.5 |
| Diluted earnings per share | 91.67%-1.5 | 89.55%-10.5 | -150.00%-7.5 | 98.39%-1.5 | 66.67%-1.5 | -460.25%-18 | -425.28%-100.5 | -192.10%-3 | -841.95%-93 | -171.37%-4.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
